1. Home
  2. ULBI vs ACHV Comparison

ULBI vs ACHV Comparison

Compare ULBI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULBI
  • ACHV
  • Stock Information
  • Founded
  • ULBI 1990
  • ACHV N/A
  • Country
  • ULBI United States
  • ACHV Canada
  • Employees
  • ULBI 536
  • ACHV N/A
  • Industry
  • ULBI Industrial Machinery/Components
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • ULBI Miscellaneous
  • ACHV Health Care
  • Exchange
  • ULBI Nasdaq
  • ACHV Nasdaq
  • Market Cap
  • ULBI 158.1M
  • ACHV 159.0M
  • IPO Year
  • ULBI 1992
  • ACHV N/A
  • Fundamental
  • Price
  • ULBI $9.52
  • ACHV $4.47
  • Analyst Decision
  • ULBI Strong Buy
  • ACHV Strong Buy
  • Analyst Count
  • ULBI 1
  • ACHV 3
  • Target Price
  • ULBI $14.00
  • ACHV $14.00
  • AVG Volume (30 Days)
  • ULBI 42.6K
  • ACHV 87.7K
  • Earning Date
  • ULBI 10-24-2024
  • ACHV 11-07-2024
  • Dividend Yield
  • ULBI N/A
  • ACHV N/A
  • EPS Growth
  • ULBI 283.01
  • ACHV N/A
  • EPS
  • ULBI 0.60
  • ACHV N/A
  • Revenue
  • ULBI $168,946,000.00
  • ACHV N/A
  • Revenue This Year
  • ULBI $10.59
  • ACHV N/A
  • Revenue Next Year
  • ULBI $8.72
  • ACHV N/A
  • P/E Ratio
  • ULBI $15.73
  • ACHV N/A
  • Revenue Growth
  • ULBI 17.37
  • ACHV N/A
  • 52 Week Low
  • ULBI $6.36
  • ACHV $3.03
  • 52 Week High
  • ULBI $13.39
  • ACHV $5.98
  • Technical
  • Relative Strength Index (RSI)
  • ULBI 41.90
  • ACHV 51.93
  • Support Level
  • ULBI $9.24
  • ACHV $4.23
  • Resistance Level
  • ULBI $9.69
  • ACHV $4.64
  • Average True Range (ATR)
  • ULBI 0.38
  • ACHV 0.16
  • MACD
  • ULBI -0.03
  • ACHV 0.03
  • Stochastic Oscillator
  • ULBI 23.68
  • ACHV 69.43

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks: